Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01724502 · ClinicalTrials.gov registry record · NA

Mitochondrial Dysfunction in Diabetes

A NA study of Diabetes and Obese, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
16
Enrollment target
1
Study location

NCT01724502: Completed NA study of Diabetes and Obese, sponsored by Mayo Clinic.

NCT01724502 is a NA study of Diabetes and Obese that has completed, run by Mayo Clinic. The registered enrollment target is 16 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01724502, a NA study of Diabetes and Obese, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
16 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine whether insulin resistance is accompanied by "exercise resistance". Investigators will use mass spectrometry and proteomics analysis to test the hypothesis is that a bout of exercise that increases mitochondrial protein abundance in lean, healthy individuals is less effective in insulin resistant patients.

Primary Outcome

Protein concentration will be determined from muscle biopsies by the method of Lowry. 75 micrograms of muscle lysate proteins will be separated on a 10% Sodium Dodecyl Sulfate Polyacrylamide Gel, and then visualized with Coomassie stain. The gel lane will be cut into cubes, digested with trypsin and cleaned, then protein abundance will be determined using spectral counting.

Conditions Studied

Interventions

  • BEHAVIORAL Exercise and muscle biopsies

Study Locations (1)

Arizona

  • Mayo Clinic in Arizona - Scottsdale

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2012-09
Est. Completion 2014-03
Phase NA
Mayo Clinic

2,844 total trials

What the finished NCT01724502 record still lists

NCT01724502 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (99% lower).

The record links to 2 conditions, with Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Exercise and muscle biopsies is the first listed.

NCT01724502 reports a single indexed study location in Arizona.

Frequently Asked Questions

What is clinical trial NCT01724502 about?

NCT01724502 is a clinical study titled "Mitochondrial Dysfunction in Diabetes". The purpose of this study is to determine whether insulin resistance is accompanied by "exercise resistance". Investigators will use mass spectrometry and proteomics analysis to test the hypothesis is that a bout of exercise that increases mitochondrial protein abundance in lean, healthy individuals...

What is the current status of trial NCT01724502?

This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2012-09. Estimated completion is 2014-03.

What conditions does trial NCT01724502 study?

This clinical trial studies the following conditions: Diabetes, Obese.

What interventions are being tested in trial NCT01724502?

The interventions under investigation include: Exercise and muscle biopsies (BEHAVIORAL).

Who is sponsoring clinical trial NCT01724502?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01724502 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01724502's enrollment target sits among peer trials

16 319th of 338 higher than 17 of 338 other Diabetes trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02422641 · 16 participants · Phase 2

    Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

  • NCT02851758 · 16 participants · NA

    Transplantation of Autologously Derived Mitochondria Following Ischemia

  • NCT03291028 · 16 participants

    Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma

  • NCT03425526 · 16 participants · Phase 1

    Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01724502, the US trial registry maintained by the National Library of Medicine. NCT01724502 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.